On March 11, the Shanghai index rose 0.41%, the Shenzhen Component Index rose 0.62% and the gem index rose 1.15%. According to the data of the after hours dragon tiger list, a total of 51 stocks were listed on the Dragon Tiger list due to changes on the same day, and the largest net capital inflow was Andon Health Co.Ltd(002432) ( Andon Health Co.Ltd(002432) .sz), amounting to 483 million yuan.
According to 21 INVESTMENT smart monitoring, there are institutions on the Dragon Tiger list of 20 stocks, and there are 7 stocks involved in the Dragon Tiger list with northward funds.
483 million fund raised Andon Health Co.Ltd(002432) , 380 million fund fled Guangzhou Wondfo Biotech Co.Ltd(300482)
Among the 51 dragon and tiger stocks on the list, 34 stocks were net bought and 17 stocks were net sold. Among them, Andon Health Co.Ltd(002432) was the largest net purchase of funds, amounting to 483 million yuan, accounting for 10.62% of the total transaction amount Andon Health Co.Ltd(002432) on that day, the closing price rose by 10%, and the turnover rate was 17.13%.
The largest net outflow of funds in the dragon and tiger list is Guangzhou Wondfo Biotech Co.Ltd(300482) ( Guangzhou Wondfo Biotech Co.Ltd(300482) . SZ), with a net sale of 380 million yuan, accounting for 10.23% of the total transaction amount Guangzhou Wondfo Biotech Co.Ltd(300482) closed up 20% and the turnover rate was 21.26%.
Institutions bought 12 shares and sold 8 shares
On March 11, 20 individual stocks were listed as institutions, with a total net sales of 274 million yuan. Specifically, institutions net buy 12 shares and net sell 8 shares
Among them, Zhejiang Orient Gene Biotech Co.Ltd(688298) ( Zhejiang Orient Gene Biotech Co.Ltd(688298) . SH) was the largest net purchase amount of institutions, and closed up 18.01% on the same day, with a turnover rate of 16.74%. There are four institutions in the top five trading business departments, with a total net purchase of 512.3 million yuan, accounting for 16.51% of the total transaction amount.
Guangzhou Wondfo Biotech Co.Ltd(300482) ( Guangzhou Wondfo Biotech Co.Ltd(300482) . SZ) was the largest single stock sold by institutions, and closed up 20% on the same day, with a turnover rate of 21.26%. Among the top five trading business departments, there are four institutions with a net sales of 459.72 million yuan, accounting for 12.37% of the total transaction amount.
Northbound capital net bought 4 shares and sold 3 shares
On March 11, BEIXIANG capital participated in 7 stocks in the dragon and tiger list, with a total net sales of 7.9661 million yuan among them, the Shanghai Stock connect net bought 2 shares and sold 1 share, with a total net purchase of 3.8415 million yuan; Shenzhen Stock connect net bought 2 shares and sold 2 shares, with a total net sales of 118076 million yuan.
the largest net purchase amount of northbound funds is Hongfa Technology Co.Ltd(600885) ( Hongfa Technology Co.Ltd(600885) . SH), net purchase amount is 733863 million yuan, accounting for 7.18% of the total transaction amount The largest amount of net sales was Zhejiang Orient Gene Biotech Co.Ltd(688298) ( Zhejiang Orient Gene Biotech Co.Ltd(688298) . SH), was 942058 million yuan, accounting for 3.04% of the total turnover. The closing price of the day rose 18.01% and the turnover rate was 16.74%.
It is worth noting that institutions and BEIXIANG capital jointly net sold Caissa Tosun Development Co.Ltd(000796) , Guangzhou Wondfo Biotech Co.Ltd(300482) and other two shares; There were differences on Hongfa Technology Co.Ltd(600885) , Jiugui Liquor Co.Ltd(000799) , Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) , Zhejiang Orient Gene Biotech Co.Ltd(688298) , institutions sold Hongfa Technology Co.Ltd(600885) 297 million yuan net, and northbound funds bought 733863 million yuan net; The net sales of institutions are Jiugui Liquor Co.Ltd(000799) 126 million yuan, and the net purchase of funds from north is 265402 million yuan; The net sales of institutions are Shijiazhuang Yiling Pharmaceutical Co.Ltd(002603) 644124 million yuan, and the net purchase of funds from north is 247284 million yuan; Net purchases of Zhejiang Orient Gene Biotech Co.Ltd(688298) 512 million yuan by institutions and net sales of 942058 million yuan by northbound funds.
(statement: the contents of the article are for reference only and do not constitute investment suggestions. Investors operate accordingly at their own risk.)
